[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]




Скачать 217.57 Kb.
Название[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]
страница2/8
Дата15.10.2012
Размер217.57 Kb.
ТипДокументы
1   2   3   4   5   6   7   8
Bioconjug Chem 16 (1): 80-89, 2005

Cavarga I; Brezani P; Fedorocko P; Miskovsky P; Bobrov N; Longauer F; Rybarova S; Mirossay L; Stubna J. Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing. Phytomedicine 12 (9): 680-683, 2005

Cecic I; Serrano K; Gyongyossy-Issa M; Korbelik M. Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy. Cancer Lett 225 (2): 215-223, 2005

Chabrier-Rosello Y; Foster TH; Perez-Nazario N; Mitra S; Haidaris CG. Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity. Antimicrob Agents Chemother 49 (10): 4288-4295, 2005

Chan AL; Juarez M; Allen R; Volz W; Albertson T. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces. Photodermatol Photoimmunol Photomed 21 (2): 72-78, 2005

Chan WM; Ohji M; Lai TY; Liu DT; Tano Y; Lam DS. Choroidal neovascularisation in pathological myopia: an update in management. Br J Ophthalmol 89 (11): 1522-1528, 2005

Chang CJ; Wilder-Smith P. Topical application of photofrin for photodynamic diagnosis of oral neoplasms. Plast Reconstr Surg 115 (7): 1877-1886, 2005

Charamisinau I; Happawana G; Evans G; Rosen A; Hsi RA; Bour D. Semiconductor laser insert with uniform illumination for use in photodynamic therapy. Appl Opt 44 (24): 5055-5068, 2005

Chaudhry NA; Lavaque AJ; Shah A; Liggett PE. Photodynamic therapy for choroidal neovascular membrane secondary to optic nerve drusen. Ophthalmic Surg Lasers Imaging 36 (1): 70-72, 2005

Chen B; Pogue BW; Hoopes PJ; Hasan T. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int J Radiat Oncol Biol Phys 61 (4): 1216-1226, 2005

Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model. Clin Cancer Res 11 (2 Pt 1): 720-727, 2005

Chen B; Pogue BW; Hasan T. Liposomal delivery of photosensitising agents. Expert Opin Drug Deliv 2 (3): 477-487, 2005

Chen HM; Yu CH; Tu PC; Yeh CY; Tsai T; Chiang CP. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Lasers Surg Med 37 (2): 114-122, 2005

Chen HM; Chen CT; Yang H; Lee MI; Kuo MY; Kuo YS; Wang YP; Tsai T; Chiang CP. Successful treatment of an extensive verrucous carcinoma with topical 5-aminolevulinic acid-mediated photodynamic therapy. J Oral Pathol Med 34 (4): 253-256, 2005

Chen LF; Ke YQ; Yang ZL; Wang SQ; Xu RX. [Effect of photodynamic therapy combined with interstitial chemotherapy for gliomas]. Di Yi Jun Yi Da Xue Xue Bao 25 (1): 116-118, 2005

Chen WR; Korbelik M; Bartels KE; Liu H; Sun J; Nordquist RE. Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant. Photochem Photobiol 81 (1): 190-195, 2005

Chen Y; Gryshuk A; Achilefu S; Ohulchansky T; Potter W; Zhong T; Morgan J; Chance B; Prasad PN; Henderson BW; Oseroff A; Pandey RK. A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy. Bioconjug Chem 16 (5): 1264-1274, 2005

Chen Y; Miclea R; Srikrishnan T; Balasubramanian S; Dougherty TJ; Pandey RK. Investigation of human serum albumin (HSA) binding specificity of certain photosensitizers related to pyropheophorbide-a and bacteriopurpurinimide by circular dichroism spectroscopy and its correlation with in vivo photosensitizing efficacy. Bioorg Med Chem Lett 15 (13): 3189-3192, 2005

Chen Y; Zheng X; Dobhal MP; Gryshuk A; Morgan J; Dougherty TJ; Oseroff A; Pandey RK. Methyl pyropheophorbide-a analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacy. J Med Chem 48 (11): 3692-3695, 2005

Chew H; Maberley DA; Ma P; Chang A; Maberley A. Socioeconomic status and clinical features of patients undergoing photodynamic therapy or transpupillary thermotherapy for subfoveal choroidal neovascularization due to age-related macular degeneration. Can J Ophthalmol 40 (3): 384-388, 2005

Chilin A; Dodoni G; Frezza C; Guiotto A; Barbieri V; Di Lisa F; Canton M. 4-hydroxymethyl-1,6,8-trimethylfuro[2,3-h]quinolin-2(1H)-one induces mitochondrial dysfunction and apoptosis upon its intracellular oxidation. J Med Chem 48 (1): 192-199, 2005

Chiti G; Municchi M; Paschetta V; Roncucci G. LC-MS/MS determination in rabbit plasma of the main photoproduct of RLP068/Cl, a cationic sensitizer proposed for photodynamic therapy (PDT) of microbial infections. J Chromatogr B Analyt Technol Biomed Life Sci 814 (1): 133-141, 2005

Chiu LL; Sun CH; Yeh AT; Torkian B; Karamzadeh A; Tromberg B; Wong BJ. Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblast co-culture. Lasers Surg Med 37 (3): 231-244, 2005

Chiu SM; Xue LY; Azizuddin K; Oleinick NL. Photodynamic therapy-induced death of HCT 116 cells: Apoptosis with or without Bax expression. Apoptosis , 2005

Choi EK; Kim MH. [Photodynamic therapy for unresectable cholangiocarcinoma: does it really increase the survival time?]. Korean J Gastroenterol 45 (6): 446, 2005

Choi YH; Ko SH; Kim SJ; Lee WY; Park JH; Lee JM. Induction of cell death by photodynamic therapy with a new synthetic photosensitizer DH-I-180-3 in undifferentiated and differentiated 3T3-L1 cells. Biochem Biophys Res Commun 337 (4): 1059-1064, 2005

Christie NA; Patel AN; Landreneau RJ. Esophageal palliation--photodynamic therapy/stents/brachytherapy. Surg Clin North Am 85 (3): 569-582, 2005

Chung AK; Gauba V; Ghanchi FD. Photodynamic therapy (PDT) using verteporfin for juxtafoveal choroidal neovascularisation (CNV) in angioid streaks (AS) associated with pseudoxanthoma elasticum: 40 months results. Eye , 2005

Ciulla TA; Criswell MH; Snyder WJ; Small W. Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris. Br J Ophthalmol 89 (1): 113-119, 2005

Clarke H; Pallister CJ. The impact of anaemia on outcome in cancer. Clin Lab Haematol 27 (1): 1-13, 2005

Colombo LL; Vanzulli SI; Villanueva A; Canete M; Juarranz A; Stockert JC. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine. Int J Oncol 27 (4): 1053-1059, 2005

Comer GM; Ciulla TA; Heier JS; Criswell MH. Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration. Expert Opin Emerg Drugs 10 (1): 119-135, 2005

Conio M; Cameron AJ; Chak A; Blanchi S; Filiberti R. Endoscopic treatment of high-grade dysplasia and early cancer in Barrett's oesophagus. Lancet Oncol 6 (5): 311-321, 2005

Constable I; Shen WY; Rakoczy E. Emerging biological therapies for age-related macula degeneration. Expert Opin Biol Ther 5 (10): 1373-1385, 2005

Cordoba F; Braathen LR; Weissenberger J; Vallan C; Kato M; Nakashima I; Weis J; von F, V. 5-aminolaevulinic acid photodynamic therapy in a transgenic mouse model of skin melanoma. Exp Dermatol 14 (6): 429-437, 2005

Criswell MH; Ciulla TA; Lowseth LA; Small W; Danis RP; Carson DL. Anastomotic vessels remain viable after photodynamic therapy in primate models of choroidal neovascularization. Invest Ophthalmol Vis Sci 46 (6): 2168-2174, 2005

Crnolatac I; Huygens A; van Aerschot A; Busson R; Rozenski J; de Witte PA. Synthesis, in vitro cellular uptake and photo-induced antiproliferative effects of lipophilic hypericin acid derivatives. Bioorg Med Chem 13 (23): 6347-6353, 2005

Cunderlikova B; Moan J; Sjaastad I. pH dependent uptake of porphyrin-type photosensitizers by solid tumor cells in vitro is not induced by modification of transmembrane potential. Cancer Lett 222 (1): 39-47, 2005

Curcio CA; Presley JB; Millican CL; Medeiros NE. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp Eye Res 80 (6): 761-775, 2005

Dabrowska A; Gos M; Janik P. "Bystander effect" induced by photodynamically or heat-injured ovarian carcinoma cells (OVP10) in vitro. Med Sci Monit 11 (9): BR316-BR324, 2005

Dalbasti T; Kilinc E. Microelectrode for In Vivo Real-Time Detection of NO. Methods Enzymol 396: 584-592, 2005

Degen A; Gabrecht T; Wagnieres G; Caduff R; Imthurn B; Wyss P. Influence of the menstrual cycle on aminolevulinic acid induced protoporphyrin IX fluorescence in the endometrium: in vivo study. Lasers Surg Med 36 (3): 234-237, 2005

Degenring RF; Jonas JB. Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization. Acta Ophthalmol Scand 83 (5): 621, 2005

del Carmen MG; Rizvi I; Chang Y; Moor AC; Oliva E; Sherwood M; Pogue B; Hasan T. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J Natl Cancer Inst 97 (20): 1516-1524, 2005

Demidova TN; Hamblin MR. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother 49 (6): 2329-2335, 2005

Demidova TN; Gad F; Zahra T; Francis KP; Hamblin MR. Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria. J Photochem Photobiol B 81 (1): 15-25, 2005

Demidova TN; Hamblin MR. Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol 71 (11): 6918-6925, 2005

Depasse F; Sensebe L; Seghatchian J; Andreu G; Samama MM. The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices. Transfus Apher Sci 33 (1): 63-69, 2005

Desmettre TJ; Mordon SR. Comparison of laser beam intensity profiles produced by photodynamic therapy (PDT) and transpupillary thermotherapy (TTT) lasers. Lasers Surg Med 36 (4): 315-322, 2005

Di Stasio B; Frochot C; Dumas D; Even P; Zwier J; Muller A; Didelon J; Guillemin F; Viriot ML; Barberi-Heyob M. The 2-aminoglucosamide motif improves cellular uptake and photodynamic activity of tetraphenylporphyrin. Eur J Med Chem 40 (11): 1111-1122, 2005

Di Venosa G; Casas A; Fukuda H; Perotti C; Batlle A. No cross-resistance between ALA-mediated photodynamic therapy and nitric oxide. Nitric Oxide 13 (3): 155-162, 2005

Di Venosa G; Perotti C; Fukuda H; Batlle A; Casas A. Sensitivity to ALA-PDT of cell lines with different nitric oxide production and resistance to NO cytotoxicity. J Photochem Photobiol B 80 (3): 195-202, 2005

Diamond KR; Malysz PP; Hayward JE; Patterson MS. Quantification of fluorophore concentration in vivo using two simple fluorescence-based measurement techniques. J Biomed Opt 10 (2): 024007, 2005

Dietze A; Peng Q; Selbo PK; Kaalhus O; Muller C; Bown S; Berg K. Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin. Br J Cancer 92 (11): 2004-2009, 2005

Dietze A; Engesaeter B; Berg K. Transgene delivery and gelonin cytotoxicity enhanced by photochemical internalization in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis patients. Photochem Photobiol Sci 4 (4): 341-347, 2005

Dole KC; Chen Q; Hetzel FW; Whalen LR; Blanc D; Huang Z. Effects of photodynamic therapy on peripheral nerve: in situ compound-action potentials study in a canine model. Photomed Laser Surg 23 (2): 172-176, 2005

Dolgachev V; Oberley LW; Huang TT; Kraniak JM; Tainsky MA; Hanada K; Separovic D. A role for manganese superoxide dismutase in apoptosis after photosensitization. Biochem Biophys Res Commun 332 (2): 411-417, 2005

Donaldson MJ; Lim L; Harper CA; Mackenzie J; Campbell G. Primary treatment of choroidal amelanotic melanoma with photodynamic therapy. Clin Experiment Ophthalmol 33 (5): 548-549, 2005

Donnelly RF; McCarron PA; Lightowler JM; Woolfson AD. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J Control Release 103 (2): 381-392, 2005

Donnelly RF; McCarron PA; Woolfson AD. Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy. Photochem Photobiol 81 (4): 750-767, 2005

Dorward AM; Fancher KS; Duffy TM; Beamer WG; Walt H. Early neoplastic and metastatic mammary tumours of transgenic mice detected by 5-aminolevulinic acid-stimulated protoporphyrin IX accumulation. Br J Cancer 93 (10): 1137-1143, 2005

Du H; Bay BH; Mahendran R; Olivo M. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer. Cancer Lett , 2005

Du HY; Olivo M; Chen YJ; Yip G; Tan PH; Matsumoto K; Tsujimoto M; Bay BH. Expression of Y-Box binding protein-1 following hypericin-mediated photodynamic therapy in well-differentiated nasopharyngeal cancer in vivo. Int J Mol Med 16 (5): 865-868, 2005

Dube A; Sharma S; Gupta PK. Evaluation of chlorin p6 for photodynamic treatment of squamous cell carcinoma in the hamster cheek pouch model. Oral Oncol , 2005

Duffner F; Ritz R; Freudenstein D; Weller M; Dietz K; Wessels J. Specific intensity imaging for glioblastoma and neural cell cultures with 5-aminolevulinic acid-derived protoporphyrin IX. J Neurooncol 71 (2): 107-111, 2005

Dutta S; Ray D; Kolli BK; Chang KP. Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro. Antimicrob Agents Chemother 49 (11): 4474-4484, 2005

Dysart JS; Singh G; Patterson MS. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem Photobiol 81 (1): 196-205, 2005

Dysart JS; Patterson MS. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys Med Biol 50 (11): 2597-2616, 2005

Embleton ML; Nair SP; Heywood W; Menon DC; Cookson BD; Wilson M. Development of a novel targeting system for lethal photosensitization of antibiotic-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother 49 (9): 3690-3696, 2005

Eter N; Spaide RF. Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photodynamic therapy. Retina 25 (6): 691-696, 2005

Eubanks LM; Dickerson TJ; Janda KD. Vitamin B2-mediated cellular photoinhibition of botulinum neurotoxin A. FEBS Lett 579 (24): 5361-5364, 2005

Evans AV; Robson A; Barlow RJ; Kurwa HA. Treatment of port wine stains with photodynamic therapy, using pulsed dye laser as a light source, compared with pulsed dye laser alone: a pilot study. Lasers Surg Med 36 (4): 266-269, 2005

Falciatore A; Merendino L; Barneche F; Ceol M; Meskauskiene R; Apel K; Rochaix JD. The FLP proteins act as regulators of chlorophyll synthesis in response to light and plastid signals in Chlamydomonas.
1   2   3   4   5   6   7   8

Похожие:

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSelected Anomalies and Diseases of the Eye

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconHepatic Liver Diseases – Methods for Diagnosis and

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconAbengoechea-hernandez, S., Elizalde-montagut, J. & Fideliz de la paz-dalisay, M. (2007) [Photodynamic therapy in adult-onset foveomacular vitelliform

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconБад «нагипол» в терапии алиментарно-зависимых патологий. Baa "nagipol" in therapy alimentary-dependent’s diseases
Ключевые слова: биологически-активная добавка (бад), пивные дрожжи, автолизат, алиментарно-зависимые патологии, витамины, аминокислоты,...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEndometriosis. Gynaecological diseases of children and teenagers
...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSession 2: Fourier Transform Infrared (ft ir) & Fluorescence Spectroscopy

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconThe American Occupational Therapy Foundation & American Occupational Therapy Association’s

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon2. Device choice

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon“Assistive Device for Calendar Production”

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEye Tracking and e-Learning

Разместите кнопку на своём сайте:
Библиотека


База данных защищена авторским правом ©lib.znate.ru 2014
обратиться к администрации
Библиотека
Главная страница